Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Today’s podcast covers my conversation with Jill Sisco, president of the Acromegaly Community, about the recent meetings with the Food and Drug Administration (FDA), the US governmental entity responsible for approving new medications. Our conversation focuses on the original meeting held in 2021 and a recent listening session where the AC provided additional feedback to the FDA.
We caught up with Sheila a few weeks ago at the Acromegaly Community Conference near San Francisco. We had a captivating chat about Mycapssa (oral octreotide) and about Amryt’s start in Dublin, Ireland, just six years ago, its philosophy, brand, and plans.
This session presents more musing based on the actual practice of pituitary medicine, including growth hormone, the recent Covid-19 surge, dexamethasone dose adjustments, an interesting empty sella case with an enlarged pituitary gland, gadolinium, and the connection between mold and pituitary tumors misinformation flying around on the internet, adrenal and pituitary Cushing’s, and a look at telemedicine changes that may not be that good for patients.
Dr. Lewis Blevins talks with guest Dr. Saleh Aldasouqi, Professor, Chief, Division of Endocrinology and Metabolism, and Clinician at Michigan State University Specialty Center, Endocrinology Clinic, about Biotin use and its interference with laboratory tests.
Our live talk session from May 12 is now available on-demand with guests Jill Sisco, president of the Acromegaly Community, and Sharmyn McGraw from the Pacific Neuroscience Institute. This was a fascinating perspective on the challenges and opportunities for patient advocacy programs.
A highly informational “live-talk” session from Dr. Blevins about the indications for pituitary surgery for patients with pituitary adenomas, and critical information for patients with Central Adrenal Insufficiency due to hypothalamic or pituitary disease.
In session three, we cover the many possible complications from pituitary surgery in terms of pituitary function and the anatomy around the gland.
Dr. Lewis Blevins discusses the normal ranges of endocrine lab tests and shares examples from his pituitary practice. Also, our guest this week, Pat Gildroy, who manages the Diabetes Insipidus Facebook group, Got DI, joins us for a fascinating discussion about this condition.
In the first Pituitary World News LIVE TALK radio-style program, our guest Dr. Manish Aghi discusses the many facets of headaches and pituitary tumors.
In today’s podcast directed to physicians, PWN co-founder Dr. Lewis Blevins discusses the drug Recolev® (levoketoconazole) recently approved by the FDA to treat endogenous Cushing’s Syndrome.
In this podcast directed to physicians, Dr. Lewis Blevins shares his vast experience of 30 years treating patients with central hypothyroidism.
In the last podcast in the series on the drugs available to manage hypercortisolism, Dr. Blevins discusses mifepristone, trade name Korlym®.